Results 41 to 50 of about 740,744 (261)
The hallmarks of COVID-19 disease
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel coronavirus that has caused a worldwide pandemic of the human respiratory illness COVID-19, resulting in a severe threat to public health and safety. Analysis of the genetic tree suggests that SARS-CoV-2 belongs to the same Betacoronavirus group as severe acute respiratory syndrome
Daolin Tang, Paul Comish, Rui Kang
openaire +4 more sources
Thromboembolic Disease in COVID-19
Coronavirus disease 2019 (COVID-19) was initially recognized in late December 2019 and has quickly spread globally with over 114 million reported cases worldwide at the time of this publication. For the majority of patients infected with COVID-19, the clinical manifestations are absent or mild.
Tarmey, Tara +3 more
openaire +3 more sources
The recent passing away of Dr. Tomisaku Kawasaki, who first described what is now known as Kawasaki Disease (KD), and recent reports of a multisystem inflammatory disease in children associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (MIS-C), makes a review on KD and MIS-C timely.
Gkoutzourelas, Athanasios +2 more
openaire +2 more sources
COVID-19 and neurodegenerative diseases.
The pandemic of Coronavirus Disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues, and SARS-CoV-2 variants continue to emerge. In addition to typical fever and respiratory symptoms, many patients with COVID-19 experience a variety of neurological complications.
Fu, Y.-W., Xu, H.-S., Liu, S.-J.
openaire +2 more sources
Objectives The COVID-19 pandemic has highlighted the importance and complexity of a country’s ability to effectively respond. The Joint External Evaluation (JEE) assessment was launched in 2016 to assess a country’s ability to prevent, detect and respond
Luis Hernandez +10 more
doaj +1 more source
COVID-19 and autoimmune diseases
Purpose of review The aim of this study was to evaluate the relationship between infection with SARS-CoV-2 and autoimmunity. Recent findings Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome (SARS) associated coronavirus 2 (SARS-
Liu, Yu, Sawalha, Amr H., Lu, Qianjin
openaire +3 more sources
Cerebrovascular Disease in COVID-19 [PDF]
Coronavirus disease 19 (COVID-19) is a pandemic originating in Wuhan, China, in December 2019. Early reports suggest that there are neurologic manifestations of COVID-19, including acute cerebrovascular disease. We report a case of COVID-19 with acute ischemic stroke.
Michael F. Goldberg +3 more
openaire +2 more sources
COVID-19 and oncological disease
Coronavirus disease 2019 (COVID-19), a respiratory tract infection caused by the severe acute respiratory syndrome coronavirus named SARS-CoV-2, initially emerged in China in late 2019. The rapid global spread of this novel virus led the World Health Organization declare a pandemic with > 30,000,000 confirmed cases, 946,000 deaths and > 21,000 ...
Tomáš, Šálek +6 more
openaire +2 more sources
Ocular Behçet disease and COVID-19 [PDF]
Purpose to study in patients with Behçet disease and ocular involvement (OBD) the presence of SARS-CoV-2 infection and its influence on the course of OBD. Methods all the patients with OBD living in Lazio, one Italian region, and ...
Accorinti M. +3 more
openaire +2 more sources
COVID-19 and Glomerular Diseases
COVID-19 is a systemic disease, and the kidney is one of the target organs of infection. Kidney injury is common and can occur in up to 40% of patients. Several glomerular diseases have been reported in association with COVID-19. Some are likely related to COVID-19 whereas many are likely coincidental.
Klomjit, Nattawat +3 more
openaire +2 more sources

